Latest Research

Microfluidics can help to determine the antioxidant capacity of RBCs to reduce the risk of anaemia during chemotherapy

Abstract

“Oxidative stress is one of the key factors that leads to red blood cells (RBCs) aging, and impairs their biomechanics and oxygen delivery. It occurs during numerous pathological processes and causes anaemia, one of the most frequent side effects of cancer chemotherapy. Here, we used microfluidics to simulate the microcirculation of RBCs under oxidative stress induced by tert-Butyl hydroperoxide. Oxidative stress was expected to make RBCs more rigid, which would lead to decrease their transit velocity in microfluidic channels. However, single-cell tracking combined with cytological and AFM studies reveals cell heterogeneity, which increases with the level of oxidative stress. The data indicates that the built-in antioxidant defence system has a limit exceeding which haemoglobin oxidation, membrane, and cytoskeleton transformation occurs. It leads to cell swelling, increased stiffness and adhesion, resulting in a decrease in the transit velocity in microcapillaries. However, even at high levels of oxidative stress, there are persistent cells in the population with an undisturbed biophysical phenotype that retain the ability to move in microcapillaries. Developed microfluidic analysis can be used to determine RBCs’ antioxidant capacity for the minimization of anaemia during cancer chemotherapy.

 

a Schematic view of the device; b an image of a single microchannel with control RBCs; c 1.5 mM tBuOOH treatment can lead to microchannel’s occlusion. t1 and t2 marks indicate the capturing points for determining cells’ transit time in microchannels.” Reproduced under Creative Commons Attribution 4.0 International License from Besedina, N.A., Skverchinskaya, E.A., Shmakov, S.V. et al. Persistent red blood cells retain their ability to move in microcapillaries under high levels of oxidative stress. Commun Biol 5, 659 (2022).


Figures and the abstract are reproduced from
Besedina, N.A., Skverchinskaya, E.A., Shmakov, S.V. et al. Persistent red blood cells retain their ability to move in microcapillaries under high levels of oxidative stress. Commun Biol 5, 659 (2022). https://doi.org/10.1038/s42003-022-03620-5

Read the original article: Microfluidic device for investigation of RBCs transport in microcapillaries

Pouriya Bayat

Published by
Pouriya Bayat

Recent Posts

Exploring Microfluidic Leukapheresis for Pediatric Leukemia

Leukapheresis is a critical treatment for children with symptomatic hyperleukocytosis, a condition where extremely high…

March 3, 2025

Understanding Microbiome Influence on Melanoma Treatment Using Microfluidics Technology

Despite the significant advancements brought by immune checkpoint inhibitors (ICIs) in melanoma treatment, patient responses…

February 18, 2025

Microfluidic Research on C. elegans for Developmental Toxicity Testing: A Novel Machine Learning Approach

Traditional developmental toxicity (DevTox) studies largely rely on mammalian models to assess chemical impacts on…

February 4, 2025

Advancing Liquid Biopsies with High-Throughput Microfluidics

Circulating tumor cells (CTCs) hold the potential for cancer diagnosis and monitoring, offering a non-invasive…

January 20, 2025

Development of a Microfluidic Impedance Flow Cytometer

Leukocyte differentiation and counting are critical for clinical diagnostics but are hindered by the low…

January 6, 2025

Enhanced Screening of Proteolytic Microorganisms Using a Passive Droplet Microfluidic Platform

Screening for microbial proteolytic activity is essential in various biotechnological applications, including bioenergy, food processing,…

December 17, 2024